chrisvoncsefalvay/vaers-outcomes huggingface dataset:
24 hrs after the vaccine I was about to have lunch and started feeling dizzy, couldnt hear the people in the room and began to fall as I was advised and someone in the room caught me.  I was laid down and administered water until I felt better.  I went back to my worksite while having to use the hand rails because my vision was blurred and I finally made it to my desk.  I was then transported to the ER and my BS was taken which was 85.  I was given IV fluids, a chest xray was performed, a UA and pregnancy test was done, EKG and a CBC done which all was negative and normal.  From my knees down felt shaky the remainder of the week.  I had a visit with my PCP the following week on Tuesday and had a sugar test done which was also normal and by the end of that week all symptoms had resided
he has not had any issues since receiving the 2nd dose; a consumer had received a extra dose of PNEUMOVAX 23; This spontaneous report was received from a pharmacist and refers to a male patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 21-OCT-2018, the patient was vaccinated with the first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0.5 ml (exact dose, site and route of administration, lot# and expiration date were not reported) for prophylaxis. On 11-OCT-2019, he received an extra dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0.5 ml (exact dose, site and route of administration, lot# and expiration date were not reported) for prophylaxis. The patient had not had any issues since receiving the second dose.
Pricked herself with the adjuvant liquid only; Inappropriate dose of vaccine administered; May have been exposed to the adjuvant / Patient is in her first trimester; This prospective pregnancy case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. The patient's last menstrual period was on an unknown date and estimated date of delivery was 9th February 2021. The patient received Shingrix at an unknown time during the pregnancy. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication, inappropriate dose of vaccine administered and vaccine exposure during pregnancy. On an unknown date, the outcome of the inappropriate preparation of medication, inappropriate dose of vaccine administered and vaccine exposure during pregnancy were unknown. The pregnancy was ongoing.  Additional details were provided as follows: The age at vaccination was not reported. The patient pricked herself with the adjuvant liquid only, which led to inappropriate preparation of medication, inappropriate dose of vaccine administered and vaccine exposure during pregnancy. The patient's approximate due date was 9th Ferbruary 2021. The reporter consented to follow up.   Follow-up information was received on 15th April 2021: After completion of all the follow up attempts the case was considered as pregnancy lost to follow up.
8-24-18 hives both forearms and thighs. More hives on left side of body. First noticed symptoms 10 AM 8/24-18 and went to ER 8/24/18 at 1030 AM. Given BENADRYL and methylprednisolone 4 mg tapering dose.
Post 4th Anthrax shot, pt developed pruritic papular rash one week later which has persisted until today. Treating with antihistamine and oral steroids.
Patient reported having pressure in upper chest and tightness in her head 5 minutes into receiving  her Pfizer booster. Patient declined to get her vitals taken or to be seen by MD. Chest pressure resolved a few minutes with rest. Headache continued to persist at the end of her observation period. Patient reported similar headaches with past 2 doses. No medication given. Patient left the building with her partner.
Patient had her second Moderna vaccine and 5 minutes later she started having tingling in her arm.  She stated the tingling resolved in 1 hour .  I spoke to her at 4:15pm.  All tingling resolved but she was experiencing a some numbness in the arm, she stated this could have been from how she was sitting or from her rheumatoid arthritis
Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Mild, Systemic: Numbness (specify: facial area, extremities)-Severe, Additional Details: Patient states that she cannot lift her arm and has trouble getting dressed. She is having severe pain at the injection site although it has been 6 days since the vaccination. She called her PCP who told her to take ibuprofen and if pain persists then go to the ER. She will call us back to update us after trying ibuprofen and/or ER visit.
Achy, fever, chills.  Rash on neck and chest.  Swollen lymph nodes
Narrative: 72yo male with history of prostate cancer, HTN, HLD, chronic Afib, CVA in 6/2016, EtOH use disorder and liver cirrhosis decompensated by ascites, squamous cell carcinoma on cheek, and lung adenocarcinoma. Died on 06/19/21 at home. Patient was administered covid vaccinations on 03/15/21 and 04/12/21. Appears patient died due to complications of his numerous disease states and death is not related to the covid vaccinations.
Patient's arm is red and warm at injection site and she feels like she has a fever "feels terrible".
Patient reports waking up with a sore arm, tingling all over, headache, hand numbness, and a purple colored finger.
PATIENT WAS GIVEN JANSSEN COVID VACCINE ON 8/13/21 AT APPROXIMATELY 12:00PM. PATIENT DID NOT DISCLOSE THAT HE HAD PREVIOUSLY RECEIVED 2 DOSES OF MODERNA COVID VACCINE IN MAY/JUNE AT ANOTHER PHARMACY, DESPITE BEING PROMPTED ABOUT PREVIOUS VACCINES -- STATED THAT HE HAD ONLY RECEIVED PNEUMONIA AND FLU IN THE LAST FEW YEARS. PATIENT WAS ASKED ABOUT PREVIOUS COVID-19 VACCINES, HE STATED THIS WAS HIS FIRST DOSE AND THAT HE WAS LOOKING FOR THE ONE SHOT VACCINE, DISCUSSED THAT THIS WAS THE JANSSEN VACCINE, AND HE WAS CONFIRMED THAT WAS WHAT HE WANTED. A DISCUSSION FOLLOWED ABOUT THE EFFICACY OF THE VACCINE COMPARED TO THE OTHERS ON THE MARKET SPECIFICALLY WITH THE DELTA VARIENT, VACCINE RATES, AND THE IMPORTANCE OF GETTING VACCINATED (APPROXIMATLY A 10 MINUTE DISCUSSION/REVIEW OF THE VACCINE AND OTHERS ON THE MARKET). AT NO TIME DID THE PATIENT DISCLOSE HE HAD PREVIOUSLY RECEVIED IT.   ERROR WAS NOTED UPON LOGGING INTO THE RECORD SYSTEM. PATIENT WAS IMMEDIATELY CONTACTED, STATED THAT HE FORGOT TO MENTION IT, AND THOUGHT IT WOULDN'T BE A PROBLEM SINCE IT WAS SO LONG AGO. PATIENT COUNSELED ON THE DANGERS OF RECEIVING A VACCINE OUT OF SCHEDULE, PATIENT STATED IT WAS HIS FAULT AND ASKED IF HE COULD CALL SOMEONE TO TELL THEM HE DIDN'T REPORT IT WHEN HE WAS ASKED. PROVIDER EXPLAINED THAT THE INCIDENT WOULD HAVE TO BE LOGGED AS AN ERROR. PATIENT CONFIRMED THAT HE NEGLECTED TO DISCLOSE THE PREVIOUS VACCINE TO ME. VACCINE LOGGED IN SYSTEM WITH AN ANNOTATION. HLR 8/13/21
This spontaneous report as received from a 70 year old female consumer with asthma and allergy to several antibiotics reporting on herself. The consumer's medical history included bronchitis. On approximately 07-MAR-2011, "about 2 years ago", the consumer was vaccinated with a dose of ZOSTAVAX (lot # not reported) in the right arm. The consumer reported that on 15-DEC-2012, she got shingles. The consumer stated that the shingles appeared on the same arm that she received the vaccination in. The patient sought medical attention. The patient received treatment for the adverse event. The outcome of shingles was reported as recovered/resolved. Additional information has been requested.
It was reported that a 44 year old male received a Fluzone '99-'00 and an unspecified vaccination on 10/29/99. Reportedly, on 10/31/99, the pt developed body aches, injection site pain, muscle spasms, headache, stiff neck and muscle cramps in legs. From additional information received on 12/9/99, it was reported that 24 hours, post vax, the pt developed soreness at the injection site, tingling in left side, numbness, muscle weakness and stiffness, headaches and muscle spasms from neck to toes. The pt saw his primary physician, an orthopedic specialist and allergist. The pt has a referral for neurologist. Follow up #1: During internal auditing of all files, it was deemed necessary to amend the report by updating the adverse event coding (deleted twitching and added myasthenia and paresthenia).
Person received first shot of COVID vaccine by Moderna today at 11:05am, then experienced dizziness 5 minutes after. Her blood pressure was at 191/92 with HR of 94 at 11:20am, then retaken at 11:40AM with values of BP=163/77 and HR of 95. SHe also experienced rash at injection site and in chest/breasts.
Patient received Moderna Covid19 vaccine on the 18th of March. Patient began to experience symptoms the next day (shortness of breath, general body pains) on the 19th.  Discovered that patient had bilateral PE on the 23rd. Physicians unable to confirm or deny if vaccine was a contributing factor, but due to timing I am reporting this. Patient received treatment for ~24 hours and
Moderna shot 1 8/31/2021. Started with submental mass 9/13/2021. Seen in primary care clinic 9/15/2021. Patient reports febrile at home 9/16/2021. Presents to emergency department 9/17/2021, CT neck obtained and abnormal (results in next section). ENT consult placed (was not seen by ENT in ED). Patient return to emergency department 9/20/2021 with increased size submental mass and rash to trunk, arms, legs. CT chest/abdomen/pelvis obtained and abnormal. Labs obtained and abnormal. Moderna shot 2 given 9/23/2021. 9/28/2021 submental lymph node biopsy. 10/7/2021 PET scan. 10/23/2021 patient started with swelling of bilateral hands and wrists, pain bilateral hands, wrists, knees, right shoulder. Seen primary care 10/27/2021, x-rays ordered, repeat labs drawn. X-rays done 10/28/2021. Patient presented to local emergency department 11/21/2021 with confusion, admitted with hypercalcemia, AKI, metabolic encephalopathy, hospital stay 5 days. Bone marrow biopsy. Discharge diagnosis: Hypercalcemia, AKI, metabolic encephalopathy, suspected extrapulmonary sarcoidosis, suspected sarcoid myopathy. Repeat labs 11/30/2021. Face-to-face rheumatology consult 12/10/2021. Repeat labs 12/15/2021. No current official diagnosis known. Rheumatology describes sarcoidosis remains in differential but labs/biopsies don?t match. Lymphoma/myeloma still in differential but labs/biopsies don?t match. Pending Oncology consult. Current theory is this is vaccine related.
Woke up the day after being vaccinated (10/24/19) and noticed a small circle of redness with a lump at site of vaccine.  The next day (10/25/19)it got bigger.  Patient marked the area.  Patient states today (10/25/19)it is warm to the touch.  Patient says she took  benadryl the day after being vaccinated (10/24/19) but that it didn't help.
Injection site (right outer thigh) is swollen, red, has a huge knot in it and is hot to the touch. It is about the size of her fist, maybe 3 inches in diameter.
This spontaneous report as received from a pharmacist refers to a patient of unknown demographics. No concurrent conditions or medical history were provided. On 18-MAR-2016, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 injection (lot # L031459 with expiry date: 30-APR-2017; strength, dose, route and site of administration were unspecified). The administered vaccine underwent  the temperature excursion at 70 degree Fahrenheit during 1 month. It was not the case of a "data logger". No concomitant medications were reported. No adverse effect reported. This is one of several reports from the same source. Additional information has been requested.
pt recv vax 10JUL95 & 26NOV96 pt devel chickenpox w/approx 20 lesions following exposure to chickenpox;reporter also stated that pt brother devel chicken pox p/vax;
slight discomfort.; arm hurts; red welt where she got the vaccine; purple where she got the vaccine.; welt where she got the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (welt where she got the vaccine), VACCINATION SITE DISCOLOURATION (purple where she got the vaccine.), DISCOMFORT (slight discomfort.), VACCINATION SITE PAIN (arm hurts) and VACCINATION SITE ERYTHEMA (red welt where she got the vaccine) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039AZ1A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced URTICARIA (welt where she got the vaccine). On 17-May-2021, the patient experienced VACCINATION SITE DISCOLOURATION (purple where she got the vaccine.), VACCINATION SITE PAIN (arm hurts) and VACCINATION SITE ERYTHEMA (red welt where she got the vaccine). On 21-May-2021, the patient experienced DISCOMFORT (slight discomfort.). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at a dose of UNK dosage form. At the time of the report, URTICARIA (welt where she got the vaccine), VACCINATION SITE DISCOLOURATION (purple where she got the vaccine.), DISCOMFORT (slight discomfort.), VACCINATION SITE PAIN (arm hurts) and VACCINATION SITE ERYTHEMA (red welt where she got the vaccine) outcome was unknown.            Concomitant drug information does not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-162151 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-162151:Child case, brestfeeding
light little like headache; I got the booster shot on the 17Sep2021; This is a spontaneous report from a contactable consumer (patient). A 75-years-old patient of an unspecified gender received third dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 17Sep2021 (age at vaccination 75 years) as dose 3 (booster), single for covid-19 immunization. The patient medical history was none. There were no concomitant medications. Patient got the booster shot on friday (17Sep2021), Thursday Friday any way thursday afternoon patient got light headache and they came and went but this morning (18Sep2021) patient woke up and got this same headache it was not really severe patient still could do all regular activity so it was not something 'doing' but it was just did not go away." patient wonder was there anything should do about it or let it went or what. Therapeutic measure (Tylenol) were taken as a result of headache. The outcome of events was reported as not recovered.  This follow-up was being submitted to notify that the lot/batch number was not available despite the follow-up attempts were made.  Follow-up attempts were completed. No further information was expected.
bump on neck; rash on neck; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BLISTER (bump on neck) and RASH (rash on neck) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced BLISTER (bump on neck) and RASH (rash on neck). At the time of the report, BLISTER (bump on neck) and RASH (rash on neck) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
MMR given 6APR92 pt devel mumps MAY92; 8JUL92 mom says can't remember exact details but pt had nodes in throat area & on both sides of neck; lasted 15 days;
Day 1 - pain & redness at injection site, day 2- worsening pain/swelling/redness, day 3 - fever, muscle aches, body pain, blisters around injection site, pain/swelling/redness at injection site. day 4 - swelling largely gone, site still red & painful with red area larger than before. Patient went to a clinic at this time. Patient initially diagnosed with cellulitis, but then sent to emergency room & diagnosed with an allergic reaction.
Heart palpitations, chest tightness. Uncomfortable when trying to sleep. Right side of chest particularly. Consistently for 2 days now.  I took the first dose of Pfizer on 05/17/2021 & took the second dose on 12/29/2021.
Experienced heart palpitations over the course of 12 hours. I went to the emergency room at the recommendation of my doctor.
Diarrhea started few days after vaccination, still on going now 2 months after vaccination, with positive rotavirus Ag detection in stool, patient diagnosed recently with SCID.
Experienced dizziness the first week after vaccination; Axillary lymph node swelling to arm of injection; Axillary lymph node swelling to arm of injection; hands and feet tingling/numbness/Feels as if hands and feet are falling asleep often; hands and feet tingling/numbness/Feels as if hands and feet are falling asleep often; This is a spontaneous report received from a contactable nurse (who is also the patient). A 25-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration, on 30Dec2020 14:00, at single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. On 06Jan2021 at 14:00, first week after the vaccination, the patient experienced dizziness, axillary lymph node swelling to arm of injection 1 week until now after vaccination, and hands and feet tingling/numbness at random times of the day and feels as if hands and feet are falling asleep often. The events resulted to "doctor or other healthcare professional office/clinic visit". No treatment for the events was given. The outcome of the events was not recovered. The events were assessed as non-serious.  Information on the lot/batch number has been requested.
Fever -  low grade temperature and erythematous generalized, clairaudant exanthema from face to trunk / extremities,  more prominent on trunk. He also had an URI since 12/13/09. Patient seen today (12/17/09).
Pt's grandma called to report fever of 102.4F & crying for 20min;Seen by MD suspecting strep infect stated pt did not sleep well last night crying fever down sl w/APAP cool wash cloth use;
Initial information received on 25-Mar-2019 regarding an unsolicited valid non-serious case received from Other health care professional. This case involves a 12 months old male patient who experienced received vaccine DAPTACEL. The patient's past medical history, concomitant medication and family history were not provided. On 21-Mar-2019, the patient received a 0.5ml dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE lot C5169AA, expiry date 16-Mar-2019 via unknown route in unknown administration site. It was an actual medication error due to expired vaccine used. It was reported that 1 year old child received an expired dose (expiry date 16-Mar-2019) of DAPTACEL on 21-Mar-2019. It was unknown whether patient experienced any adverse reaction after the injection. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender- none.
3 weeks after  my shot I broke-out all over with a rash like i never had before---So I got oral meds shot and topical cream--no improvement after a week--- went and got another shot more meds after another week was almost back to normal--my Dr. told me not to go and get my 2nd shot of Moderna till my system was back to normal--So i missed my second shot and reached out to cancel my appointment and then to get another it took me till 3/1 to get another appointment.
soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in her arm) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027b21a, 004c21a and 045521a) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in her arm). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency and IBUPROFEN SODIUM (IBUPROFEN [IBUPROFEN SODIUM]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (soreness in her arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication was not reported.   This case was linked to MOD-2021-417004, MOD-2021-416998 (Patient Link).
This spontaneous report as received from other health professional (Medical Assistant) refers to multiple unspecified patients of unknown age and gender. Pertinent medical histories, drug reactions or allergies and concomitant therapies were not provided. On unspecified dates since January 2016 (Onset approximated to 2016), the patients were vaccinated with improperly stored doses of ROTATEQ VIAL (lot # K011948 with an expiry date 07-JUN-2016, lot # L013197 with an expiry date 29-JAN-2016) (doses and frequencies unspecified) intramuscularly. No adverse effects were reported.  It was reported that vaccines were not discontinued. This is one of the several reports received from the same reporter.  Additional information has been requested.
Systemic: Fainting / Unresponsive-Mild, Additional Details: PATIENT WAS GIVEN COVID VACCINE AT 9:13AM. Patient was slightly nervous, covid vaccine was adminstered as normal routine. Patient was tense, slight blood at adminstration site. Left arm was wiped with pad, and given band-aid. After 30 seconds patient passed out on chair with faint response. I IMMEDIATELTY called 911 and ambulance came to observe patient. Ptaient became response, mother assured she had "Anxiety" and she left pharmacy.
Arm pain; High fever; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), PYREXIA (High fever) and ARTHRALGIA (Joint pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Nov-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), PYREXIA (High fever) and ARTHRALGIA (Joint pain). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at a dose of 2. At the time of the report, PAIN IN EXTREMITY (Arm pain), PYREXIA (High fever) and ARTHRALGIA (Joint pain) outcome was unknown.            Concomitant information was not provided.  Treatment information was not provided.